LONDON - Initial results from a large study in the U.K. found that an antibody drug reduced death in hospitalized COVID-19 patients who faced the highest risk from the virus. The study was led by the ...

President Donald Trump is now "in a race" against the coronavirus, the CEO of biotechnology company Regeneron said Friday after the drug maker provided a dose of its experimental antibody treatment to ...

The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...

The FDA has authorized a new version of Regeneron’s COVID-19 drug that can be given by injection, which should make it easier to give to patients. Regeneron said June 4 the FDA is now allowing the ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

TARRYTOWN, N.Y. - A COVID-19 antibody cocktail developed by U.S. drugmaker Regeneron offered strong protection against symptomatic infection when given to people living with someone else infected with ...

NEW YORK, Oct 9 (Reuters) - The U.S. government expects to be able to provide at no cost more than 1 million doses of antibody treatments for COVID-19 similar to the one President Donald Trump ...